Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 179 | 2023 | 6773 | 8.600 |
Why?
|
Adenoma | 40 | 2023 | 2174 | 3.770 |
Why?
|
Diet | 56 | 2023 | 7937 | 2.870 |
Why?
|
Meat | 13 | 2018 | 592 | 2.360 |
Why?
|
Colonic Polyps | 16 | 2023 | 542 | 2.310 |
Why?
|
Feeding Behavior | 14 | 2021 | 3188 | 1.920 |
Why?
|
Colonic Neoplasms | 22 | 2022 | 2542 | 1.760 |
Why?
|
Gallstones | 4 | 2022 | 286 | 1.510 |
Why?
|
Prospective Studies | 151 | 2023 | 53290 | 1.420 |
Why?
|
Microsatellite Instability | 23 | 2023 | 684 | 1.300 |
Why?
|
Mutagens | 4 | 2015 | 168 | 1.140 |
Why?
|
Precancerous Conditions | 6 | 2021 | 975 | 1.130 |
Why?
|
Health Personnel | 19 | 2020 | 3219 | 1.120 |
Why?
|
Adenomatous Polyps | 3 | 2021 | 107 | 1.090 |
Why?
|
Follow-Up Studies | 94 | 2023 | 39052 | 1.080 |
Why?
|
Risk Factors | 141 | 2023 | 72296 | 1.070 |
Why?
|
Prostatitis | 2 | 2015 | 102 | 1.010 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 12 | 2022 | 1038 | 0.990 |
Why?
|
Diverticulitis | 7 | 2021 | 171 | 0.990 |
Why?
|
Proportional Hazards Models | 60 | 2022 | 12356 | 0.970 |
Why?
|
Dairy Products | 5 | 2021 | 498 | 0.970 |
Why?
|
Incidence | 66 | 2023 | 20952 | 0.910 |
Why?
|
Calcium, Dietary | 9 | 2020 | 526 | 0.890 |
Why?
|
Pelvic Pain | 2 | 2015 | 274 | 0.880 |
Why?
|
Vitamin D | 17 | 2021 | 3224 | 0.880 |
Why?
|
Middle Aged | 188 | 2022 | 213390 | 0.820 |
Why?
|
Monosaccharides | 1 | 2021 | 70 | 0.770 |
Why?
|
Fusobacterium nucleatum | 5 | 2021 | 163 | 0.770 |
Why?
|
C-Peptide | 10 | 2023 | 419 | 0.750 |
Why?
|
Aged | 145 | 2021 | 163288 | 0.690 |
Why?
|
Diet Surveys | 10 | 2021 | 1173 | 0.670 |
Why?
|
Seafood | 4 | 2016 | 384 | 0.670 |
Why?
|
Prostatic Neoplasms | 15 | 2023 | 11126 | 0.660 |
Why?
|
Flavonoids | 3 | 2023 | 443 | 0.660 |
Why?
|
Adult | 147 | 2023 | 214052 | 0.650 |
Why?
|
Motor Activity | 5 | 2015 | 2715 | 0.630 |
Why?
|
Hyperinsulinism | 4 | 2023 | 415 | 0.610 |
Why?
|
Diet, Mediterranean | 4 | 2021 | 700 | 0.610 |
Why?
|
Female | 190 | 2023 | 380193 | 0.610 |
Why?
|
Tumor Microenvironment | 14 | 2022 | 3590 | 0.610 |
Why?
|
Risk Assessment | 30 | 2022 | 23336 | 0.600 |
Why?
|
Male | 178 | 2023 | 350115 | 0.600 |
Why?
|
United States | 82 | 2023 | 69872 | 0.590 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2019 | 251 | 0.590 |
Why?
|
Dietary Fiber | 8 | 2019 | 760 | 0.590 |
Why?
|
Nurses | 15 | 2021 | 2462 | 0.580 |
Why?
|
Folic Acid | 7 | 2021 | 1300 | 0.570 |
Why?
|
Humans | 254 | 2023 | 744366 | 0.560 |
Why?
|
Carotenoids | 5 | 2013 | 624 | 0.560 |
Why?
|
Colonoscopy | 16 | 2023 | 1367 | 0.560 |
Why?
|
Exercise | 11 | 2021 | 5615 | 0.540 |
Why?
|
Plants, Edible | 1 | 2015 | 30 | 0.540 |
Why?
|
CpG Islands | 12 | 2022 | 1170 | 0.520 |
Why?
|
Body Mass Index | 28 | 2023 | 12721 | 0.520 |
Why?
|
Proto-Oncogene Proteins B-raf | 16 | 2022 | 2043 | 0.520 |
Why?
|
Cyclooxygenase 2 | 6 | 2020 | 612 | 0.510 |
Why?
|
Eggs | 1 | 2016 | 184 | 0.500 |
Why?
|
Adiponectin | 8 | 2019 | 1101 | 0.500 |
Why?
|
Cohort Studies | 53 | 2021 | 40559 | 0.490 |
Why?
|
Insulin | 7 | 2019 | 6582 | 0.480 |
Why?
|
Fatty Acids, Omega-3 | 4 | 2020 | 1344 | 0.480 |
Why?
|
Risk | 24 | 2020 | 9688 | 0.470 |
Why?
|
Fishes | 3 | 2019 | 569 | 0.450 |
Why?
|
Tooth Loss | 3 | 2020 | 197 | 0.450 |
Why?
|
Obesity | 18 | 2023 | 12746 | 0.440 |
Why?
|
Life Style | 12 | 2023 | 3835 | 0.440 |
Why?
|
Fruit | 8 | 2022 | 1142 | 0.440 |
Why?
|
Vegetables | 8 | 2022 | 1182 | 0.430 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 227 | 0.430 |
Why?
|
Quinoxalines | 2 | 2015 | 290 | 0.430 |
Why?
|
Multivariate Analysis | 24 | 2020 | 12244 | 0.420 |
Why?
|
Adolescent Behavior | 1 | 2021 | 1151 | 0.420 |
Why?
|
DNA Methylation | 20 | 2022 | 4285 | 0.420 |
Why?
|
Prognosis | 37 | 2022 | 29060 | 0.420 |
Why?
|
Plant Extracts | 1 | 2015 | 471 | 0.410 |
Why?
|
Long Interspersed Nucleotide Elements | 8 | 2020 | 338 | 0.400 |
Why?
|
Financial Management | 2 | 2023 | 160 | 0.400 |
Why?
|
Adipose Tissue | 4 | 2020 | 3280 | 0.380 |
Why?
|
Carcinoma, Signet Ring Cell | 3 | 2018 | 83 | 0.380 |
Why?
|
Pathology, Molecular | 4 | 2019 | 326 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2023 | 11726 | 0.360 |
Why?
|
Dietary Supplements | 8 | 2020 | 3296 | 0.360 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.340 |
Why?
|
Chondroitin | 2 | 2020 | 66 | 0.330 |
Why?
|
Rectal Neoplasms | 6 | 2021 | 1205 | 0.330 |
Why?
|
Beverages | 5 | 2023 | 821 | 0.330 |
Why?
|
Aspirin | 7 | 2017 | 3283 | 0.320 |
Why?
|
Glucosamine | 2 | 2020 | 132 | 0.320 |
Why?
|
Imidazoles | 2 | 2015 | 1206 | 0.320 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2014 | 2016 | 0.310 |
Why?
|
Alcohol Drinking | 9 | 2021 | 3966 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2019 | 9240 | 0.310 |
Why?
|
Food | 3 | 2023 | 772 | 0.310 |
Why?
|
Case-Control Studies | 29 | 2023 | 21748 | 0.300 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 4 | 2019 | 357 | 0.300 |
Why?
|
Calcium | 4 | 2023 | 5755 | 0.290 |
Why?
|
Diverticulitis, Colonic | 2 | 2019 | 128 | 0.290 |
Why?
|
Adenocarcinoma | 7 | 2020 | 6364 | 0.280 |
Why?
|
Resistance Training | 2 | 2020 | 164 | 0.280 |
Why?
|
Adiposity | 4 | 2021 | 1806 | 0.280 |
Why?
|
Defecation | 2 | 2021 | 188 | 0.270 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2017 | 315 | 0.270 |
Why?
|
Cooking | 3 | 2018 | 313 | 0.270 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2019 | 563 | 0.270 |
Why?
|
Growth Differentiation Factor 15 | 3 | 2015 | 176 | 0.260 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 9 | 2022 | 1692 | 0.260 |
Why?
|
Blood Glucose | 2 | 2017 | 6254 | 0.250 |
Why?
|
Periodontal Diseases | 2 | 2020 | 449 | 0.250 |
Why?
|
Postmenopause | 5 | 2021 | 2460 | 0.250 |
Why?
|
Molecular Epidemiology | 5 | 2019 | 468 | 0.250 |
Why?
|
Early Detection of Cancer | 6 | 2022 | 3086 | 0.250 |
Why?
|
Epidemiology | 2 | 2019 | 287 | 0.240 |
Why?
|
Dietary Sucrose | 2 | 2018 | 246 | 0.240 |
Why?
|
Arylamine N-Acetyltransferase | 2 | 2014 | 86 | 0.240 |
Why?
|
Odds Ratio | 14 | 2020 | 9849 | 0.230 |
Why?
|
Sweetening Agents | 2 | 2018 | 296 | 0.230 |
Why?
|
Logistic Models | 12 | 2022 | 13409 | 0.230 |
Why?
|
Fructose | 2 | 2023 | 289 | 0.230 |
Why?
|
Adolescent | 20 | 2023 | 85779 | 0.230 |
Why?
|
Neoplasm Staging | 14 | 2021 | 11031 | 0.230 |
Why?
|
Rectum | 5 | 2020 | 904 | 0.230 |
Why?
|
Colon | 7 | 2020 | 1772 | 0.220 |
Why?
|
Inflammation | 10 | 2020 | 10637 | 0.220 |
Why?
|
Mutation | 21 | 2023 | 29786 | 0.220 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1837 | 0.210 |
Why?
|
Poultry | 3 | 2022 | 82 | 0.210 |
Why?
|
Food, Fortified | 2 | 2021 | 191 | 0.210 |
Why?
|
Coffee | 2 | 2017 | 578 | 0.210 |
Why?
|
Time Factors | 20 | 2021 | 40075 | 0.200 |
Why?
|
Keloid | 1 | 2022 | 50 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2021 | 15520 | 0.200 |
Why?
|
Sulfur Compounds | 1 | 2021 | 31 | 0.200 |
Why?
|
Sigmoidoscopy | 3 | 2021 | 156 | 0.200 |
Why?
|
Vitamins | 2 | 2021 | 1623 | 0.200 |
Why?
|
Biliary Tract | 1 | 2022 | 134 | 0.200 |
Why?
|
Obesity, Abdominal | 3 | 2019 | 361 | 0.190 |
Why?
|
Health Surveys | 7 | 2021 | 4036 | 0.190 |
Why?
|
Ferritins | 3 | 2013 | 590 | 0.190 |
Why?
|
Alkylating Agents | 1 | 2021 | 139 | 0.190 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 7 | 2022 | 890 | 0.190 |
Why?
|
Smoking | 9 | 2021 | 8987 | 0.190 |
Why?
|
Carcinoma | 3 | 2017 | 2375 | 0.190 |
Why?
|
Mendelian Randomization Analysis | 2 | 2017 | 967 | 0.190 |
Why?
|
Biliary Tract Neoplasms | 1 | 2022 | 178 | 0.180 |
Why?
|
Survival Analysis | 9 | 2021 | 10252 | 0.180 |
Why?
|
Cholelithiasis | 1 | 2021 | 414 | 0.180 |
Why?
|
Antioxidants | 2 | 2010 | 1659 | 0.180 |
Why?
|
Vitamin D-Binding Protein | 1 | 2020 | 129 | 0.170 |
Why?
|
Genes, ras | 2 | 2020 | 690 | 0.170 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2014 | 507 | 0.170 |
Why?
|
Chemoprevention | 1 | 2022 | 319 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 12 | 2021 | 17446 | 0.170 |
Why?
|
Leisure Activities | 3 | 2015 | 311 | 0.170 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2020 | 548 | 0.170 |
Why?
|
Granulocytes | 1 | 2021 | 548 | 0.170 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 165 | 0.170 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
Estrone | 1 | 2020 | 240 | 0.170 |
Why?
|
Amines | 2 | 2013 | 276 | 0.160 |
Why?
|
Syndrome | 2 | 2015 | 3252 | 0.160 |
Why?
|
Waist Circumference | 3 | 2020 | 917 | 0.160 |
Why?
|
Weight Gain | 3 | 2019 | 2293 | 0.160 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 316 | 0.160 |
Why?
|
Polyps | 1 | 2020 | 189 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 532 | 0.160 |
Why?
|
Age Factors | 8 | 2021 | 18373 | 0.160 |
Why?
|
Meat Products | 1 | 2018 | 99 | 0.160 |
Why?
|
Vitamin E | 1 | 2002 | 869 | 0.160 |
Why?
|
Bifidobacterium | 1 | 2018 | 100 | 0.160 |
Why?
|
Young Adult | 16 | 2021 | 56429 | 0.160 |
Why?
|
Zinc | 3 | 2022 | 684 | 0.160 |
Why?
|
Waist-Hip Ratio | 2 | 2018 | 517 | 0.150 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1888 | 0.150 |
Why?
|
Phaseolus | 1 | 2017 | 15 | 0.150 |
Why?
|
Exercise Therapy | 2 | 2015 | 904 | 0.150 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 546 | 0.150 |
Why?
|
Neoplasms | 7 | 2023 | 21696 | 0.140 |
Why?
|
Progestins | 1 | 2019 | 306 | 0.140 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2014 | 123 | 0.140 |
Why?
|
Contraceptives, Oral | 2 | 2016 | 564 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 77 | 0.140 |
Why?
|
Liver Neoplasms | 3 | 2022 | 4253 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2017 | 2282 | 0.140 |
Why?
|
Digestive System Neoplasms | 1 | 2016 | 86 | 0.140 |
Why?
|
Cholesterol | 2 | 2023 | 2919 | 0.140 |
Why?
|
Caffeine | 2 | 2017 | 699 | 0.130 |
Why?
|
Flavones | 1 | 2015 | 66 | 0.130 |
Why?
|
Nuts | 1 | 2018 | 257 | 0.130 |
Why?
|
Health Occupations | 4 | 2021 | 224 | 0.130 |
Why?
|
Flavanones | 1 | 2015 | 71 | 0.130 |
Why?
|
Estradiol | 2 | 2021 | 2020 | 0.130 |
Why?
|
Anthocyanins | 1 | 2015 | 79 | 0.130 |
Why?
|
Flavonols | 1 | 2015 | 83 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.130 |
Why?
|
Cattle | 3 | 2022 | 3922 | 0.130 |
Why?
|
Cause of Death | 3 | 2021 | 3582 | 0.130 |
Why?
|
Aged, 80 and over | 16 | 2020 | 57776 | 0.130 |
Why?
|
Food Handling | 1 | 2015 | 145 | 0.130 |
Why?
|
Body Weight | 3 | 2021 | 4671 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 526 | 0.130 |
Why?
|
Energy Intake | 3 | 2018 | 2148 | 0.130 |
Why?
|
Allied Health Personnel | 1 | 2016 | 162 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 7 | 2020 | 6539 | 0.130 |
Why?
|
Breast Neoplasms | 5 | 2018 | 20824 | 0.130 |
Why?
|
Folic Acid Deficiency | 1 | 2015 | 115 | 0.130 |
Why?
|
Vitamin B 6 | 2 | 2014 | 237 | 0.120 |
Why?
|
Dietary Fats | 2 | 2022 | 2016 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 2 | 2015 | 1790 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 350 | 0.120 |
Why?
|
Genome-Wide Association Study | 7 | 2020 | 12262 | 0.120 |
Why?
|
Mass Screening | 5 | 2022 | 5253 | 0.120 |
Why?
|
California | 1 | 2018 | 1402 | 0.120 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 1 | 2014 | 30 | 0.120 |
Why?
|
Interleukin-6 | 4 | 2019 | 3203 | 0.120 |
Why?
|
ras Proteins | 3 | 2014 | 1060 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 775 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
C-Reactive Protein | 5 | 2019 | 3778 | 0.120 |
Why?
|
Prostate | 1 | 2022 | 1775 | 0.120 |
Why?
|
Body Fat Distribution | 1 | 2015 | 244 | 0.120 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15160 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4479 | 0.120 |
Why?
|
Up-Regulation | 3 | 2019 | 4222 | 0.120 |
Why?
|
Sex Factors | 8 | 2021 | 10400 | 0.120 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2013 | 68 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 2 | 2021 | 711 | 0.120 |
Why?
|
Quality of Life | 1 | 2015 | 12802 | 0.120 |
Why?
|
Age of Onset | 4 | 2021 | 3270 | 0.120 |
Why?
|
Xenobiotics | 1 | 2013 | 73 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1465 | 0.110 |
Why?
|
DNA, Neoplasm | 3 | 2013 | 1758 | 0.110 |
Why?
|
Stomach Neoplasms | 2 | 2020 | 1332 | 0.110 |
Why?
|
Colitis, Ulcerative | 2 | 2015 | 1911 | 0.110 |
Why?
|
Prostaglandins | 1 | 2014 | 405 | 0.110 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2014 | 272 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 604 | 0.110 |
Why?
|
Forecasting | 1 | 2022 | 2951 | 0.110 |
Why?
|
Testosterone | 2 | 2021 | 2419 | 0.110 |
Why?
|
Television | 1 | 2015 | 409 | 0.110 |
Why?
|
Survival Rate | 8 | 2020 | 12788 | 0.110 |
Why?
|
Crohn Disease | 2 | 2015 | 2304 | 0.110 |
Why?
|
Laxatives | 1 | 2013 | 87 | 0.110 |
Why?
|
Codon | 1 | 2014 | 611 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8432 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1203 | 0.100 |
Why?
|
Autophagy | 1 | 2020 | 1297 | 0.100 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 348 | 0.100 |
Why?
|
Receptors, Leptin | 1 | 2013 | 361 | 0.100 |
Why?
|
Snoring | 1 | 2013 | 191 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1566 | 0.100 |
Why?
|
Hemeproteins | 1 | 2011 | 62 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2504 | 0.100 |
Why?
|
Cadherins | 1 | 2016 | 907 | 0.100 |
Why?
|
Genotype | 8 | 2020 | 12952 | 0.100 |
Why?
|
Erythrocytes | 1 | 2020 | 2455 | 0.090 |
Why?
|
Iron, Dietary | 1 | 2011 | 141 | 0.090 |
Why?
|
Bacteria | 1 | 2021 | 2115 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1125 | 0.090 |
Why?
|
Blood Donors | 1 | 2012 | 355 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2015 | 850 | 0.090 |
Why?
|
Pancreatic Neoplasms | 3 | 2022 | 5263 | 0.090 |
Why?
|
Yogurt | 2 | 2020 | 72 | 0.090 |
Why?
|
Colitis | 1 | 2018 | 1170 | 0.090 |
Why?
|
Social Environment | 1 | 2015 | 1022 | 0.090 |
Why?
|
Epidemiologic Studies | 3 | 2018 | 676 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 645 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2575 | 0.090 |
Why?
|
Sleep | 2 | 2017 | 4622 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1343 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1213 | 0.080 |
Why?
|
Child | 9 | 2022 | 77709 | 0.080 |
Why?
|
Disease | 1 | 2015 | 680 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1148 | 0.080 |
Why?
|
Phenotype | 7 | 2021 | 16367 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 288 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25039 | 0.080 |
Why?
|
Models, Statistical | 2 | 2021 | 5101 | 0.080 |
Why?
|
Somatomedins | 1 | 2008 | 192 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2017 | 3873 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 990 | 0.080 |
Why?
|
Tea | 2 | 2023 | 275 | 0.080 |
Why?
|
Ethanol | 1 | 2014 | 1342 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15535 | 0.080 |
Why?
|
One-Carbon Group Transferases | 1 | 2007 | 6 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2020 | 2249 | 0.070 |
Why?
|
Betaine | 1 | 2007 | 87 | 0.070 |
Why?
|
Self Report | 4 | 2020 | 3553 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2214 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11366 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3255 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2505 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 2873 | 0.070 |
Why?
|
Factor Analysis, Statistical | 2 | 2006 | 977 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1837 | 0.070 |
Why?
|
Lymphocyte Count | 2 | 2020 | 793 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2008 | 596 | 0.070 |
Why?
|
Choline | 1 | 2007 | 493 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15078 | 0.070 |
Why?
|
Databases, Factual | 5 | 2019 | 7730 | 0.060 |
Why?
|
Hot Temperature | 2 | 2013 | 1356 | 0.060 |
Why?
|
Leptin | 1 | 2013 | 1600 | 0.060 |
Why?
|
Animals | 11 | 2022 | 168768 | 0.060 |
Why?
|
Body Height | 1 | 2011 | 1578 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2016 | 2938 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2021 | 77460 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3476 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2943 | 0.060 |
Why?
|
Vitamin A | 1 | 2007 | 615 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10183 | 0.060 |
Why?
|
Child, Preschool | 5 | 2021 | 41005 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4262 | 0.060 |
Why?
|
Chronic Disease | 2 | 2016 | 9145 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1903 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2428 | 0.050 |
Why?
|
Principal Component Analysis | 2 | 2017 | 940 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2003 | 624 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2015 | 19905 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2003 | 683 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7182 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2017 | 11486 | 0.050 |
Why?
|
Genetics, Population | 1 | 2007 | 934 | 0.050 |
Why?
|
beta Catenin | 2 | 2020 | 1059 | 0.050 |
Why?
|
Age Distribution | 2 | 2004 | 2902 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 9955 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3646 | 0.050 |
Why?
|
Epigenomics | 2 | 2017 | 903 | 0.050 |
Why?
|
Time | 2 | 2015 | 542 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1799 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1660 | 0.050 |
Why?
|
Carcinogens | 1 | 2003 | 466 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2016 | 5749 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 174 | 0.050 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2022 | 194 | 0.050 |
Why?
|
Hematoxylin | 1 | 2020 | 64 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 72 | 0.050 |
Why?
|
Premenopause | 2 | 2015 | 1033 | 0.050 |
Why?
|
Proctoscopy | 1 | 2020 | 42 | 0.050 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 137 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2015 | 4232 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3616 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2008 | 10943 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11525 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3751 | 0.040 |
Why?
|
Eating | 3 | 2018 | 1536 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 3707 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 976 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2021 | 395 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1572 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2019 | 87 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2002 | 651 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2011 | 12025 | 0.040 |
Why?
|
Methionine | 2 | 2014 | 590 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 97 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 240 | 0.040 |
Why?
|
Vitamin B 12 | 2 | 2014 | 527 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2018 | 3480 | 0.040 |
Why?
|
Population Surveillance | 2 | 2021 | 2616 | 0.040 |
Why?
|
Life Change Events | 1 | 2023 | 938 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4933 | 0.040 |
Why?
|
Menopause | 2 | 2002 | 1626 | 0.040 |
Why?
|
Poultry Products | 1 | 2017 | 10 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 560 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2020 | 2585 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Fish Products | 1 | 2017 | 29 | 0.040 |
Why?
|
Metabolic Equivalent | 1 | 2016 | 14 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3508 | 0.030 |
Why?
|
Pharyngeal Neoplasms | 1 | 2016 | 117 | 0.030 |
Why?
|
Diet Records | 1 | 2018 | 425 | 0.030 |
Why?
|
Constipation | 1 | 2021 | 546 | 0.030 |
Why?
|
Pedigree | 1 | 2004 | 4642 | 0.030 |
Why?
|
Postprandial Period | 1 | 2017 | 292 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1101 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5953 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1687 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2971 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 474 | 0.030 |
Why?
|
Nutritive Value | 1 | 2018 | 339 | 0.030 |
Why?
|
Tumor Necrosis Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
Gallbladder Neoplasms | 1 | 2016 | 182 | 0.030 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
Anthropometry | 1 | 2019 | 1350 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1270 | 0.030 |
Why?
|
Europe | 2 | 2015 | 3338 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 2016 | 319 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2014 | 919 | 0.030 |
Why?
|
Fatty Acids | 1 | 2022 | 1809 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2700 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2494 | 0.030 |
Why?
|
Pyridoxal Phosphate | 1 | 2013 | 127 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2015 | 802 | 0.030 |
Why?
|
Databases as Topic | 1 | 2015 | 475 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2133 | 0.030 |
Why?
|
Physicians | 1 | 2011 | 4567 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2023 | 6896 | 0.030 |
Why?
|
Men | 1 | 2012 | 63 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1813 | 0.030 |
Why?
|
Lymphocytes | 1 | 2020 | 2617 | 0.030 |
Why?
|
Quality Control | 1 | 2014 | 841 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13693 | 0.030 |
Why?
|
History, 16th Century | 1 | 2011 | 72 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 284 | 0.030 |
Why?
|
Comorbidity | 2 | 2016 | 10388 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1787 | 0.020 |
Why?
|
Mouth Neoplasms | 1 | 2016 | 601 | 0.020 |
Why?
|
Sheep | 1 | 2013 | 1437 | 0.020 |
Why?
|
Triglycerides | 1 | 2019 | 2453 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1185 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1084 | 0.020 |
Why?
|
Cell Count | 1 | 2015 | 1856 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8479 | 0.020 |
Why?
|
Genetic Variation | 2 | 2017 | 6542 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4217 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1900 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9445 | 0.020 |
Why?
|
Homocysteine | 1 | 2013 | 647 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1364 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1655 | 0.020 |
Why?
|
Infant | 2 | 2021 | 35134 | 0.020 |
Why?
|
Epidemiologic Measurements | 1 | 2008 | 23 | 0.020 |
Why?
|
Cysteine | 1 | 2013 | 873 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3587 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 2408 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2924 | 0.020 |
Why?
|
Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1485 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
Transcobalamins | 1 | 2007 | 18 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2703 | 0.020 |
Why?
|
Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.020 |
Why?
|
Prevalence | 2 | 2018 | 15221 | 0.020 |
Why?
|
Temperature | 1 | 2013 | 2204 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1433 | 0.020 |
Why?
|
Models, Biological | 2 | 2015 | 9584 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 424 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5660 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1676 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1585 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3020 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6933 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 1997 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6755 | 0.020 |
Why?
|
Antigens, CD | 1 | 2016 | 4026 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2917 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5524 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6459 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2017 | 2071 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6171 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13991 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.010 |
Why?
|
Overweight | 1 | 2015 | 2371 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 63107 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5218 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3638 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3037 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4328 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7282 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14723 | 0.010 |
Why?
|
Milk | 1 | 2004 | 450 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7798 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5856 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 25628 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8091 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5717 | 0.010 |
Why?
|
Dietary Proteins | 1 | 2005 | 963 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13286 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13035 | 0.010 |
Why?
|
Research Design | 1 | 2004 | 5984 | 0.000 |
Why?
|